Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
»
Merck, Others Look to Immunotherapy Combos as Next Frontier in Oncology
BioSpace
Mon, 03/25/24 - 11:32 am
Merck
Keytruda
immunotherapy
oncology
cancer
Castle Biosciences reveals melanoma test study findings at SSO 2024
Clinical Trials Arena
Mon, 03/25/24 - 11:29 am
Castle Biosciences
DecisionDx-UM
melanoma
clinical trials
FDA blocks approval of Regeneron's blood cancer drug over confirmatory trial enrollment
Fierce Biotech
Mon, 03/25/24 - 11:27 am
Regeneron
FDA
odronextamab
clinical trials
blood cancers
FTC weighs in on Teva's inhaler litigation against Amneal amid far-reaching patent crackdown
Fierce Pharma
Mon, 03/25/24 - 11:25 am
FTC
patents
legal
Teva Pharmaceutical
Amneal
J&J Wins FDA Nod for Pulmonary Arterial Hypertension Combo Pill
BioSpace
Mon, 03/25/24 - 11:24 am
JNJ
FDA
PAH
Opsynvi
macitentan
tadalafil
Eisai and Biogen facing delay to Leqembi in Europe
Pharmaphorum
Mon, 03/25/24 - 11:22 am
Eisai
Biogen
Leqembi
Europe
Alzheimer's disease
Axsome's sleep disorder drug succeeds in late-stage trial, shares rise
Reuters
Mon, 03/25/24 - 11:22 am
Axsome Therapeutics
narcolepsy
clinical trials
AXS-12
BioNTech gets US agency notice over default on COVID vaccine royalties
Reuters
Mon, 03/25/24 - 11:20 am
BioNTech
NIH
COVID-19
vaccines
Esperion Targets Seven-Fold Jump in Cholesterol Drug Population with FDA Label Expansion
BioSpace
Mon, 03/25/24 - 11:19 am
Esperion Therapeutics
cholesterol
Nexletol
Nexlizet
FDA
FDA authorizes new drug to protect immune compromised from Covid-19
Stat
Sun, 03/24/24 - 10:35 pm
Invivyd
Pemgarda
FDA
COVID-19
After decades of waiting, late-stage therapies may penetrate the COPD market this year
Clinical Trials Arena
Sun, 03/24/24 - 10:31 pm
COPD
drug development
Sanofi
Regeneron
Dupixent
Verona
ensifentrine
FDA’s updated RWE guidelines allow pharma marketers to make more claims
Medical Marketing and Media
Sun, 03/24/24 - 10:27 pm
FDA
RWE
real world evidence
product claims
FDA grants full approval to AbbVie's ovarian cancer therapy
Reuters
Sun, 03/24/24 - 10:25 pm
AbbVie
ovarian cancer
Elahere
How Will FDA’s New QMSR Affect Medical Device Companies?
Medical Devices and Diagnostics Industry
Sun, 03/24/24 - 10:23 pm
Medtech
devices
FDA
QMSR
March 22 2024 - Medicare to cover Novo’s weight-loss drug Wegovy for patients with heart disease
Fri, 03/22/24 - 11:08 am
Medicare to cover Novo’s weight-loss drug Wegovy for patients with heart disease
BioSpace
Fri, 03/22/24 - 10:58 am
Medicare
Novo Nordisk
weight loss
Wegovy
heart disease
J&J's Abiomed sees serious Impella recall linked to heart perforations, 49 deaths
Fierce Biotech
Fri, 03/22/24 - 10:54 am
JNJ
Abiomed
Medtech
Impella
patient deaths
device recalls
A year after the acquisition of Bellus Health, GSK planning to let go of most former Bellus employees
LinkedIn
Fri, 03/22/24 - 10:50 am
GSK
Bellus Health
M&A
layoffs
Nkarta's blood cancer CAR stalls again, with falling response rate forcing it out of the race
Fierce Biotech
Fri, 03/22/24 - 10:47 am
Nkarta
natural killer cells
car
NKX101
Medtronic claims win in Axonics patent row, pushes for jury trial
Medtech Dive
Fri, 03/22/24 - 10:44 am
Medtech
Medtronic
patents
Axonics
legal
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »